Liz Shepherd

Novome Biotechnologies

Liz Shepherd is a co-founder of Novome Biotechnologies, a pre-clinical biotech company developing engineered gut bacteria as therapeutics. Liz worked on Novome's foundational platform technology during her PhD in Justin Sonnenburg's lab at Stanford University, where she developed a strategy for reliable engraftment of engineered bacteria into the gut microbiome. She first became interested in engineering biology during her undergraduate work in David Baker's lab at the University of Washington, where she worked on an engineered enzyme to break down the gluten protein. Current efforts at Novome are focused on bringing the company's lead drug candidate into phase I clinical trials, and continuing to expand the platform into new therapeutic areas.
SynBioBeta is the leading community of entrepreneurs, investors, policymakers and enthusiasts devoted to the responsible growth of the synthetic biology field. We’re dedicated to telling the stories of the field and companies involved, building their networks, and helping them grow.
Get Social
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram